IRIS

Massignan, Tania

Massignan, Tania  

Mostra records
Risultati 1 - 20 di 20 (tempo di esecuzione: 0.06 secondi).
Titolo Anno di pubblicazione Autori Unitn File
A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein 1-gen-2016 Massignan, TaniaStincardini, ClaudiaBiasini, Emiliano +
A Drug-Based Cellular Assay (DBCA) for studying cytotoxic and cytoprotective activities of the prion protein: A practical guide 1-gen-2011 Massignan, TaniaBiasini, Emiliano +
A mutant prion protein sensitizes neurons to glutamate-induced excitotoxicity 1-gen-2013 Biasini, EmilianoMassignan, Tania +
A novel, drug-based, cellular assay for the activity of neurotoxic mutants of the prion protein 1-gen-2010 Massignan, TaniaBiasini, Emiliano +
A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity 1-gen-2017 Massignan, TaniaBiggi, SilviaStincardini, ClaudiaMaietta, GiuliaBiasini, Emiliano +
An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein 1-gen-2017 Stincardini, ClaudiaMassignan, TaniaBiggi, SilviaPancher, MichaelAdami, ValentinaMaietta, GiuliaBiasini, Emiliano +
An N-terminal polybasic domain and cell surface localization are required for mutant prion protein toxicity 1-gen-2011 Biasini, EmilianoMassignan, Tania +
Analysis of the cerebellar proteome in a transgenic mouse model of inherited prion disease reveals preclinical alteration of calcineurin activity 1-gen-2006 Biasini, EmilianoMassignan, Tania +
Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis 1-gen-2009 Basso, ManuelaMassignan, Tania +
Identification of compounds inhibiting prion replication and toxicity by removing PrPC from the cell surface 1-gen-2020 Biggi S.Pancher M.Stincardini C.Massignan T.Dalle Vedove A.Gatto P.Lolli G.Adami V.Biasini E. +
Insoluble mutant SOD1 is partly oligoubiquitinated in amyotrophic lateral sclerosis mice 1-gen-2006 Basso, ManuelaMassignan, Tania +
Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies 1-gen-2021 Massignan, TaniaBiasini, Emiliano +
Mutant prion protein expression is associated with an alteration of the rab GDP dissociation inhibitor α (GDI)/rab11 pathway 1-gen-2010 Massignan, TaniaBiasini, Emiliano +
Pharmacological inactivation of the prion protein by targeting a folding intermediate 1-gen-2021 Spagnolli, GiovanniMassignan, TaniaBiggi, SilviaRigoli, MartaLibergoli, MichelaIaneselli, AlanOrioli, SimoneBoldrini, AlbertoBonaldo, ValerioMaietta, GiuliaTosatto, LauraVignoli, BeatricePetris, GianlucaPennuto, MariaGuella, GrazianoCanossa, MarcoLolli, GrazianoBiressi, StefanoMancini, InesFaccioli, PietroBiasini, Emiliano +
Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis 1-gen-2005 Basso, ManuelaMassignan, Tania +
Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse 1-gen-2007 Massignan, TaniaBasso, ManuelaBiasini, Emiliano +
Redox regulation of cyclophilin A by glutathionylation 1-gen-2006 Massignan, TaniaBasso, ManuelaBiasini, Emiliano +
The hydrophobic core region governs mutant prion protein aggregation and intracellular retention 1-gen-2010 Biasini, EmilianoMassignan, Tania +
The N-terminal, polybasic region of PrP C dictates the efficiency of prion propagation by binding to PrP Sc 1-gen-2012 Massignan, TaniaBiasini, Emiliano +
The toxicity of a mutant prion protein is cell-autonomous, and can be suppressed by wild-type prion protein on adjacent cells 1-gen-2012 Biasini, EmilianoMassignan, Tania +